Trends in prescriptions and costs of #inhaled #medications in #chronic #obstructive #pulmonary #disease: a 19-year population-based study from #Canada. #COPD #SABA #LAMA #LABA #ICS https://t.co/CzuUn0VnWl https://t.co/gtMxjQLsJB
RT @Mo_Safavi: https://t.co/UbVljjKv0v Overuse of ICS/LABA and underuse of LAMA in #COPD? @Hamid_Tavakoli's analysis of population-based…
RT @Mo_Safavi: https://t.co/UbVljjKv0v Overuse of ICS/LABA and underuse of LAMA in #COPD? @Hamid_Tavakoli's analysis of population-based…
RT @Mo_Safavi: https://t.co/UbVljjKv0v Overuse of ICS/LABA and underuse of LAMA in #COPD? @Hamid_Tavakoli's analysis of population-based…
RT @Mo_Safavi: https://t.co/UbVljjKv0v Overuse of ICS/LABA and underuse of LAMA in #COPD? @Hamid_Tavakoli's analysis of population-based…
RT @Mo_Safavi: https://t.co/UbVljjKv0v Overuse of ICS/LABA and underuse of LAMA in #COPD? @Hamid_Tavakoli's analysis of population-based…
https://t.co/UbVljjKv0v Overuse of ICS/LABA and underuse of LAMA in #COPD? @Hamid_Tavakoli's analysis of population-based data from #BritishColumbia #RESP @CORE @ubcpharmacy @BCLungAssoc @CTS_SCT @HLIStPauls @donsin4 @KateMaJohnson https://t.co/EB2vvli